I. BASIC SCIENCES (permitted to be taken at the undergraduate pre-req level, or embedded into the program.
a. Human Anatomy
b. Human Physiology
c. Biochemistry
d. Genetics
II. FUNCTIONAL NEUROSCIENCE
a. Neuroanatomy
b. Neurophysiology
c. Neurochemistry
III. PHYSICAL EXAMINATION
a. Measurement and Interpretation of Vitals
b. Neurological Examination
c. Cardiovascular Examination
d. Respiratory Examination
e. Abdominal Examination
f. Eye, Ear, Nose, and Throat (EENT)
g. Gastrointestinal (GI)
h. Genitourinary (GU)
i. Integumentary
j. Allergic/Immunologic
k. Musculoskeletal
IV. INTERPRETATION OF LABS
a. Therapeutic Drug Monitoring
b. Other Blood/Urine Tests
c. Radiological
d. Electrocardiogram (EKG) and Brain Electrophysiology
e. Neuroimaging Techniques (to include MRI, fMRI, and CT)
f. Applied Genetics
V. PATHOLOGICAL BASES OF DISEASE
a. Pathophysiology of common clinical cardiovascular, respiratory,
gastrointestinal, hepatic, neurological, and endocrine conditions.
VI. CLINICAL MEDICINE
a. Clinical manifestations, differential diagnosis, and laboratory or radiological
evaluation of commonly encountered medical conditions
b. Special cases: children, women, and older adults, health-related conditions
(e.g., pregnancy hormone therapy), and people living with chronic health
conditions (e.g., hypertension, diabetes, HIV/AIDS, Hep C, breast and
hematological cancers and conditions)
c. Medical emergencies and their management.
VII. CLINICAL NEUROTHERAPEUTICS
a. Electrophysiology (e.g., quantitative electroencephalogram [EEG], neurofeedback).
b. Non-invasive interventions (e.g., transcranial magnetic stimulation, EEG
neurofeedback, biofeedback)
c. Electroconvulsive therapy (ECT)
VIII. SYSTEMS OF CARE
a. Coordination of care with other medical specialties
b. Consultation and referrals
c. Coordination and consultation in long-term care
IX. PHARMACOLOGY
a. Pharmacokinetics and drug delivery systems
b. Pharmacodynamic
c. Neuropharmacology
d. Toxicology
e. Mechanisms of medication interactions
X. CLINICAL PHARMACOLOGY
a. Major drug classes
b. Nutritional supplements
c. Special cases: children, women, and older adults, health-related conditions
(e.g., pregnancy hormone therapy), and people living with chronic health
conditions (e.g., hypertension, diabetes, HIV/AIDS, Hep C, breast and
hematological cancers and conditions)
XI. PSYCHOPHARMACOLOGY
a. Sedatives and Hypnotics
b. Antidepressants
c. Antipsychotics
d. Mood Stabilizers
e. Anxiolytics
f. Stimulants
g. Medications for drug dependence
h. Medication for drug adverse effects
i. Pediatric psychopharmacology
j. Geriatric psychopharmacology (including medications for cognitive impairment, polypharmacy, etc.)
k. Issues of diversity and cultural competence in pharmacological practices (including both classical categories of diversity as well as traditional practices and lifespan factors related to drug metabolism, access, acceptance, and adherence)
l. Clinical decision-making and standard practice guidelines
m. Guidelines for prescribing controlled substances
XII. PSYCHOPHARMACOLOGY RESEARCH
a. Phases of drug development
b. Clinical trials in psychiatry
c. Critical evaluation of evidence
XIII. PROFESSIONAL, ETHICAL, & LEGAL ISSUES
a. Documental (e.g., nomenclature, abbreviations, prescription writing, etc.)
b. Conflicts of interest and relationships with the pharmaceutical industry
c. Scope of practice issues
d. Diversity and equity issues related to treatment access and adherence